Latest Content

Myopia developed in 24.5% of initially nonmyopic male students over 3 years, with the highest risk among those with limited hyperopic reserve.

Leslie Scher, OD, focuses on identifying myopia and recommending treatment as soon as possible. Early intervention is shown to improve outcomes and prevent vision loss, and occurrence of severe ocular conditions.

Hamza Shah, OD, MS, FAAO, and Carolyn Majcher, OD, FAAO, weigh in on the recent FDA approval of the drug, which has been used off-label by compounding pharmacies for nearly 2 decades.

Contact lens technology has expanded beyond refractive error correction.

Catch up on the top stories in optometry during the week of August 3-7.

Steffen Schmitz-Valckenberg, MD, discusses how optical coherence tomography–based models may enable rapid, noninvasive assessment of functional loss in GA at Angiogenesis 2026.

Harrow will acquire Tyrvaya, the only FDA-approved nasal spray for dry eye disease, from Viatris for around $100 million, complementing its cyclosporine product Vevye.

Findings highlight the need for routine bilateral endothelial assessment in herpetic eye disease.

Myopia-control spectacle lenses reduce short-term progression in children by about 50%, though efficacy and long-term durability vary.

Segmented refractive index modeling reduced axial length errors linked to crystalline lens variation, but clinical validation is needed.

Physicians recommend a Mediterranean or similar diet to slow the progression of age-related macular degeneration, the leading cause of irreversible vision loss in older adults.

Pamela Theriot, OD, FAAO, discussed comprehensive eye exams, managing pediatric dry eye symptoms, and avoiding digital eye strain as back to school season begins.

Host Hamza Shah, OD, MS, FAAO, is joined by Andrew Rixon, OD, FAAO, to discuss OCT and OCTA's utility in identifying neurogeneration, inspired by Lepoittevin et al's paper "Retinal Biomarkers for Early Alzheimer's Detection: A Systematic Review of Optical Coherence Tomography (OCT) Findings."